ATE225785T1 - Tetrazolylalkyl-indolderivate als entzündungshemmende und analgetische mittel - Google Patents

Tetrazolylalkyl-indolderivate als entzündungshemmende und analgetische mittel

Info

Publication number
ATE225785T1
ATE225785T1 AT00305355T AT00305355T ATE225785T1 AT E225785 T1 ATE225785 T1 AT E225785T1 AT 00305355 T AT00305355 T AT 00305355T AT 00305355 T AT00305355 T AT 00305355T AT E225785 T1 ATE225785 T1 AT E225785T1
Authority
AT
Austria
Prior art keywords
alkyl
optionally substituted
tetrazolylalkyl
inflammatory
fully
Prior art date
Application number
AT00305355T
Other languages
English (en)
Inventor
Kazunari Nakao
Rodney William Stevens
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE225785T1 publication Critical patent/ATE225785T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00305355T 1999-07-02 2000-06-26 Tetrazolylalkyl-indolderivate als entzündungshemmende und analgetische mittel ATE225785T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB9901244 1999-07-02

Publications (1)

Publication Number Publication Date
ATE225785T1 true ATE225785T1 (de) 2002-10-15

Family

ID=11004873

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00305355T ATE225785T1 (de) 1999-07-02 2000-06-26 Tetrazolylalkyl-indolderivate als entzündungshemmende und analgetische mittel

Country Status (9)

Country Link
EP (1) EP1065206B1 (de)
JP (1) JP3337209B2 (de)
AT (1) ATE225785T1 (de)
BR (1) BR0002935A (de)
CA (1) CA2313106C (de)
DE (1) DE60000556T2 (de)
DK (1) DK1065206T3 (de)
ES (1) ES2182755T3 (de)
PT (1) PT1065206E (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL84796A (en) * 1986-12-17 1992-03-29 Merck Frosst Canada Inc Substituted n-benzyl-indoles and pharmaceutical compositions containing them
AP9801302A0 (en) * 1997-07-23 2000-01-23 Pfizer Indole compounds as anti-inflammatory/analgesic agents..
AP869A (en) * 1998-01-05 2000-09-04 Pfizer 2,3-Substituted indole compounds as anti-inflammatory and analgesic agents.

Also Published As

Publication number Publication date
JP3337209B2 (ja) 2002-10-21
ES2182755T3 (es) 2003-03-16
DK1065206T3 (da) 2002-10-28
EP1065206B1 (de) 2002-10-09
CA2313106C (en) 2004-07-13
DE60000556T2 (de) 2003-02-13
CA2313106A1 (en) 2001-01-02
BR0002935A (pt) 2001-04-03
DE60000556D1 (de) 2002-11-14
EP1065206A1 (de) 2001-01-03
JP2001031676A (ja) 2001-02-06
PT1065206E (pt) 2003-01-31

Similar Documents

Publication Publication Date Title
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
YU31303A (sh) Jedinjenja imidazola sa pripojenim arilom ili heteroarilom kao anti-inflamatorni i analgetički agensi
ATE215945T1 (de) Bicyclische carbonyl-indolverbindungen als entzündungshemmende/ analgetische wirkstoffe und als cox-2 inhibitoren
SE9904508D0 (sv) New compounds
SE0301446D0 (sv) New Compounds
PT992509E (pt) Novos derivados macrolidos
AR016977A1 (es) Compuestos de indol 2,3-sustituidos como agentes anti-inflamatorios y analgesicos, composiciones farmaceuticas, uso, intermediarios utiles, procedimientosde preparacion
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
ATE253575T1 (de) N-benzensulfonyl-l-prolin derivate und deren verwendung als bradykinin antagonisten
DK1106614T3 (da) 5-leddede, heteroarylsubstituerede 1,4-dihydropyridinforbindelser som bradykininantagonister
DE60000556D1 (de) Tetrazolylalkyl-Indolderivate als entzündungshemmende und analgetische Mittel
DE60210981D1 (de) Heteroarylheteroalkylamin derivate und deren verwendung als inhibitoren der stickoxidsynthase
ATE258934T1 (de) Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe
TW366283B (en) Compounds for treatment of arrhythmia
DK1106615T3 (da) Substituerede 1,4-dihydropyridinforbindelser som bradykininantagonister
DK0952157T3 (da) 9a, 11b-dehydroderivater af 9-oxim-3-keto-6-0-methylerythromycin
IT1274040B (it) Composizioni farmaceutiche per la prevenzione e/o il trattamento di disturbi gastrointestinali inclusa l'ulcera

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1065206

Country of ref document: EP

REN Ceased due to non-payment of the annual fee